ChREBP Blocking Peptide

• Description:

  ChREBP Blocking Peptide_x000D_ Catalog number: B2017222_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 200 µg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Carbohydrate Response Element-binding Protein, WBSCR14_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Baska A, Leis K, GaÅ‚Ä…zka P. Berberine in the Treatment of Diabetes Mellitus: A Review Endocr Metab Immune Disord Drug Targets. 2021;21(8):1379-1386._x000D_ 2: Zhang S, Guo F, Yu M, Yang X, Yao Z, Li Q, Wei Z, Feng K, Zeng P, Zhao D, Li X, Zhu Y, Miao QR, Iwakiri Y, Chen Y, Han J, Duan Y. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity J Hepatol. 2020 Dec;73(6):1482-1495._x000D_ 3: Herman MA, Samuel VT. The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis Trends Endocrinol Metab. 2016 Oct;27(10):719-730._x000D_ 4: Niss K, Jakobsson ME, Westergaard D, Belling KG, Olsen JV, Brunak S. Effects of active farnesoid X receptor on GLUTag enteroendocrine L cells Mol Cell Endocrinol. 2020 Nov 1;517:110923._x000D_ 5: Iwamoto S, Boonvisut S, Makishima S, Ishizuka Y, Watanabe K, Nakayama K. The role of TRIB1 in lipid metabolism; from genetics to pathways Biochem Soc Trans. 2015 Oct;43(5):1063-8._x000D_ 6: Maachi H, Fergusson G, Ethier M, Brill GN, Katz LS, Honig LB, Metukuri MR, Scott DK, Ghislain J, Poitout V. HB-EGF Signaling Is Required for Glucose-Induced Pancreatic β-Cell Proliferation in Rats Diabetes. 2020 Mar;69(3):369-380._x000D_ 7: Ter Horst KW, Vatner DF, Zhang D, Cline GW, Ackermans MT, Nederveen AJ, Verheij J, Demirkiran A, van Wagensveld BA, Dallinga-Thie GM, Nieuwdorp M, Romijn JA, Shulman GI, Serlie MJ. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease Diabetes Care. 2021 Feb;44(2):489-498._x000D_ 8: Zhang N, Hu Y, Ding C, Zeng W, Shan W, Fan H, Zhao Y, Shi X, Gao L, Xu T, Wang R, Gao D, Yao J. Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats Toxicol Lett. 2017 Feb 5;267:1-10._x000D_ 9: Girer NG, Murray IA, Omiecinski CJ, Perdew GH. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression J Biol Chem. 2016 Jul 15;291(29):15378-87._x000D_ 10: García-Arroyo FE, Gonzaga G, Muñoz-Jiménez I, Osorio-Alonso H, Iroz A, Vecchio M, Tapia E, Roncal-Jiménez CA, Johnson RJ, Sánchez-Lozada LG. Antioxidant supplements as a novel mean for blocking recurrent heat stress-induced kidney damage following rehydration with fructose-containing beverages Free Radic Biol Med. 2019 Sep;141:182-191. _x000D_ _x000D_ Products Related to ChREBP Blocking Peptide can be found at Proteins

• Short Description:

  Catalog Number: B2017222 (200 µg)_x000D_ ChREBP Blocking Peptide is a high quality ChREBP (Carbohydrate-Responsive Element-Binding Protein), a transcription factor that plays a crucial role in the regulation of glucose metabolism and lipogenesis. It is activated in response to high glucose levels and regulates the expression of genes involved in glycolysis and fatty acid synthesis. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  35

• Length:

  8

• Width:

  8

• Height :

  8